Claudin-1 expressions decrease in pterygium with respect to normal conjunctiva

Abstract Context: Pterygium is the fibrovascular growth of the limbal conjunctiva over cornea. This proliferative nature might have a pathogenesis associated with tight junction proteins. Objective: To investigate the tight junction protein claudin-1 expressions in pterygium with respect to normal conjunctiva. Materials and methods: This retrospective study included 28 patients who underwent pterygium surgery with autograft. Claudin-1 expressions were immunohistochemically evaluated in normal and lesional conjunctiva of the same eye. Immunohistochemical evaluation was done with regard of both the intensity and the extent of staining. The distribution of the immunohistochemical scores in pterygium and normal conjunctiva has been compared with using McNemar test. Results: The mean age of the patients was 52.2 ± 11.2 years and male/female ratio was 8/20. Among 28 samples of normal conjunctiva 25 (89.2%) demonstrated a strong immunohistochemical expression with claudin-1 whereas this rate was 10.8% for pterygium samples. Statistical analysis revealed a significant decrease in claudin-1 expressions in pterygium with respect to normal conjunctiva (p < 0.001). Discussion and conclusions: The loss of claudin-1 appears to be involved in the pathogenesis of pterygium and the future studies will elucidate the exact role of tight junction proteins in the invasive and recurrent nature of pterygium.

[1]  H. Hennies,et al.  Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis. , 2015, The American journal of pathology.

[2]  S. Ibbotson,et al.  Predicted increased risk of squamous cell carcinoma induction associated with sunbed exposure habits , 2015, The British journal of dermatology.

[3]  S. Tseng,et al.  Expression of WW domain–containing oxidoreductase WWOX in pterygium , 2015, Molecular vision.

[4]  A. Nusrat,et al.  Claudin switching: Physiological plasticity of the Tight Junction. , 2015, Seminars in cell & developmental biology.

[5]  Kraisorn Sappayatosok,et al.  Overexpression of Claudin-1 is Associated with Advanced Clinical Stage and Invasive Pathologic Characteristics of Oral Squamous Cell Carcinoma , 2015, Head and Neck Pathology.

[6]  S. Sikder,et al.  Surgical management of pterygium. , 2014, The ocular surface.

[7]  K. Malu.  Allergic conjunctivitis in Jos-Nigeria , 2014, Nigerian medical journal : journal of the Nigeria Medical Association.

[8]  Y. Soini,et al.  Claudins 1, 2, 3, 4, 5 and 7 in solar keratosis and squamocellular carcinoma of the skin. , 2013, International journal of clinical and experimental pathology.

[9]  Jingyang Wu,et al.  Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis , 2013, BMJ Open.

[10]  Xiang-ge He,et al.  Progress in the Pathogenesis of Pterygium , 2013, Current eye research.

[11]  D. Wakefield,et al.  Stem Cells, Tissue Engineering, and Hematopoietic Elements Ophthalmic Pterygium A Stem Cell Disorder with Premalignant Features , 2011 .

[12]  Leonard H Goldberg,et al.  Review ofactinic keratosis. Part I: etiology, epidemiology and clinical presentation. , 2010, Journal of drugs in dermatology : JDD.

[13]  S. Kinoshita,et al.  Tight junction transmembrane protein claudin subtype expression and distribution in human corneal and conjunctival epithelium. , 2009, Investigative ophthalmology & visual science.

[14]  K. Turksen,et al.  Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis , 2007, BMC Cancer.

[15]  D. Tan,et al.  Current concepts and techniques in pterygium treatment , 2007, Current opinion in ophthalmology.

[16]  C. Sheehan,et al.  Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. , 2007, Human pathology.

[17]  Shuji Takahashi,et al.  Immunolocalisation of E-cadherin and &bgr;-catenin in human pterygium , 2007, British Journal of Ophthalmology.

[18]  Andrew J Link,et al.  A proximal activator of transcription in epithelial-mesenchymal transition. , 2007, The Journal of clinical investigation.

[19]  F. Tsai,et al.  p53 Expression in Pterygium by Immunohistochemical Analysis: A Series Report of 127 Cases and Review of the Literature , 2005, Cornea.

[20]  Jeong-Won Lee,et al.  Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. , 2005, Gynecologic oncology.

[21]  S. Tsukita,et al.  Pores in the Wall , 2000, The Journal of cell biology.